Modulation of Endothelial Cells Fibrinolytic Activity by Platelets

Summary

Interaction between endothelial cells (EC) and platelets in culture was shown to regulate the fibrinolytic system of the aortic EC. Untreated porcine EC from aorta exhibited almost no net fibrinolytic activity and zymographic assay have shown a single fibrin lysis band of 105 kDa corresponding to a tPA-PAI complex. Incubation of aortic EC with intact platelets stimulated a cell-associated fibrinolytic activity of the urokinase type as evidenced by a plasminogen-dependent fibrin independent amidolytic activity, and the appearance of a new 48 kDa lysis band on zymography. However, in the culture medium of platelet-treated aortic EC, a new lysis band of. 92 kDa appeared with no associated amidolytic activity suggesting that the 48 kDa plasminogen activator secreted by the aortic EC after treatment with platelets is complexed to the inhibitor PAI1. This modulation of fibrinolytic activity depends on the EC origin sin0e it is not observed with pulmonary artery EC, and represents a new concept in fibrinolysis regulation by cell-cell interaction.

• References

• 1 Collen D. On the regulation and control of fibrinolysis. Thromb Haemostas 1980; 43: 78-89
• 2 Erickson LA, Schleef RR, Ny T, Loskutoff DJ. The fibrinolytic system of the vessel wall. Clin Haematol 1985; 14: 513-530
• 3 Dano K, Andreason PA, Grondhal-Hansen J, Kristensen P, Nielson LS, Schriver L. Plasminogen activation, tissue degradation and cancer. Adv Cancer Res 1985; 44: 140-239
• 4 Sprengers ED, Kluft C. Plasminogen activators inhibitors. Blood 1987; 69: 381-387
• 5 Levin EG, Loskutoff DJ. Cultured bovine endothelial cells produce both urokinase and tissue-type plasminogen activators. J Cell Biol 1982; 94: 631-636
• 6 Van-Mourik JA, Lawrence DA, Loskutoff DJ. Purification of an inhibitor of plasminogen activator (antiactivator) synthesized by endothelial cells. J Biol Chem 1984; 259: 14914-14921
• 7 Wojta J, Hoover RL, Daniel TO. Vascular origin determines plasminogen activator expression in human endothelial cells. J Biol Chem 1989; 264: 2846-2852
• 8 Schleef RR, Bevilacqua MP, Sawdey M, Gimbrone MA, Loskutoff DJ. Cytokine activation of vascular endothelium. J Biol Chem 1988; 263: 5797-5803
• 9 Johnsen UL, Lyberg T, Gaidai KS, Prydz H. Platelets stimulate thromboplastin synthesis in human endothelial cells. Thromb Haemostas 1983; 49: 69-72
• 10 Menashi S, Hornebeck W, Robert L, Caen J, Legrand Y. Interaction of platelets with endothelial cells: activation of a novel neutral protease. Exp Cell Res 1989; 183: 294-302
• 11 Patscheke H, Worner P. Platelet activation detected by turbidometric shape-change analysis. Thromb Res 1978; 12: 485-496
• 12 Legrand C, Dubernard V, Kieffer N, Nurden AT. Use of a monoclonal antibody to measure the surface expression of thrombo-spondin following platelet activation. Eur J Biochem 1988; 171: 393-399
• 13 Wu QY, Drouet L, Carrier JL, Rothschild C, Berard M, Rouault C, Caen JP, Meyer D. Differential distribution of von Willebrand factor in endothelial cells. Arteriosclerosis 1987; 7: 47-54
• 14 Ranby M, Norrman B, Wallen P. A sensitive assay for tissue plasminogen activator. Thromb Res 1982; 27: 743-749
• 15 Graneli-Piperno A, Reich E. A study of protease and protease inhibitor complexes in biological fluids. J Exp Med 1978; 146: 223-234
• 16 Laemli UK. Cleavage of structural proteins during the assembly of head of bacteriophage. Nature (London) 1970; 277: 680-685
• 17 Depletion of plasminogen Deutsch DG, Mertz ET. Plasminogen: purification from human plasma by affinity chromatography. Science 1970; 170: 1095-1096
• 18 Cajot JF, Kruithof EK O, Schleuning WD, Sordat B, Bachmann F. Plasminogen activators, plasminogen activator inhibitors and procoagulant analyzed in 20 human tumor cell lines. Int J Cancer 1986; 38: 719-727
• 19 Kruithof EK O, Tran-Thang C, Ransijn A, Bachmann F. Demonstration of a fast-acting inhibitor of plasminogen activators in human plasma. Blood 1984; 64: 907-913
• 20 Erickson LA, Ginsberg MH, Loskutoff DJ. Detection and partial characterization of an inhibitor of plasminogen activator in human platelets. J Clin Invest 1984; 74: 1465-1472
• 21 Kruithof EK O, Tran-Thang C, Bachmann F. Studies on the release of a plasminogen activator inhibitor by human platelets. Thromb Haemostas 1986; 55: 201-205
• 22 Blasi F. Surface receptors for urokinase plasminogen activator. Fibrinolysis 1988; 2: 73-84
• 23 Miles LA, Plow EF. Plasminogen receptors: ubiquitous sites for cellular regulation of fibrinolysis. Fibrinolysis 1988; 2: 61-71
• 24 Vassalli JD, Baccino D, Belin D. A cellular binding site for the Mr 55000 form of the human plasminogen activator, urokinase. J Cell Biol 1985; 100: 86-92
• 25 Declerck PJ, Alessi M-C, Verstreken M, Kruithof EK O, Juhan-Vague I, Collen D. Measurement of plasminogen activator inhibitor 1 in biological fluids with a marine monoclonal antibody-based enzyme-linked immunosorbent assay. Blood 1988; 71: 220-225